Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Tune in to Bloomberg TV on Saturday, March 14th to Watch a New Episode of Advancements
-
ISC Selected to Build and Operate the Future International Registry for Mining, Agriculture and Construction Equipment
-
Quantiphi Acquires Candyspace to Create an AI-Native Digital Experience Powerhouse
-
Bonkers Toys Signs Global Master Toy License for Gorilla Tag, The World's Most Popular VR Game
-
NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes
-
Quanta Services to Host & Webcast its 2026 Investor Day
-
Nobel Identifies New Mineralized Porphyry Copper System, Cuprita Project, Chile
-
Health In Tech to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
-
Majority of Exchanges and Venues Now Eye Prediction Markets, Acuiti Finds
-
Resolve Pain Solutions Announces Acquisition of Southcoast Spine and Pain, Territory Expands to South Carolina
-
Shareholder Alert: The Ademi Firm investigates whether Lisata Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
-
Veteran Technology Executive and Entrepreneur Keith Todd Launches Sapphire Technology Group Ltd. to Drive Sustainable Growth, Profitability in Technology Businesses
-
ACCO Brands Reports Fourth Quarter and Full Year Results and Provides Outlook for 2026
-
PyroGenesis Announces $1 Million Non-Brokered Private Placement
-
HORIZON PETROLEUM APPOINTS TREVOR WILLIAMS TO THE BOARD OF DIRECTORS
-
enGene Reports First Quarter 2026 Financial Results and Provides Business Update
-
Gulfport Energy Announces Leadership Team Changes
-
Horizon Quantum Announces Expected New Board Members and Chief Legal Officer
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer
-
Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
-
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program
-
QXO Launches Sixth Annual Campaign to Celebrate Women in Roofing
-
Dovenmuehle earns Fannie Mae STAR award for servicing excellence for the seventh time
-
Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer
-
ILS (Intelligent Legal Solutions) Raises $3M in Funding Led by Chicago Ventures
-
Kinaxis Announces Amendment to Maximize Size of Normal Course Issuer Bid
-
AN2 Therapeutics Announces $40 Million Private Placement Financing
-
Zilliant Survey: 45% of Execs Cite Tariffs as Top Pricing Threat as Food Manufacturing Volatility Becomes Structural
-
KNAPP North America Establishes Executive-Led Customer Service Model for Large-Scale Automation
-
Ionis announces changes to Board of Directors
-
Starboard Delivers Letter to Lamb Weston
-
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch
-
Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region
-
B2BROKER and Centroid Strengthen Collaboration to Enhance B2TRADER Liquidity and Risk Capabilities
-
Siris Agrees to Acquire a Majority Stake in TAKKION from Apollo Funds
-
Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients
-
Zefiro Founder Updates Shareholders on British Columbia Securities Commission Ruling Ahead of Shareholder Vote
-
Nasdaq to launch equity token design, putting issuers at the center of tokenization
-
3D Systems Reports Fourth Quarter and Full Year 2025 Financial Results
-
HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD
-
Osisko Development Announces Proceeds of $24.9 Million From Warrant Exercise
-
Omni-Lite Industries Canada Announces Leadership Transition To Accelerate Its Transformation Into A High-Performance Serial Acquiror of Niche Aerospace and Defense Businesses and Assets
-
Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)
-
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
-
Skyharbour JV Partner Denison Mines Commences Winter Drill Program at the Wheeler North Joint Venture in Northern Saskatchewan
-
iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss
-
DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk
-
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
-
Fairfield Opens Leasing for The Penstone Apartments and Townhomes in Walpole, Mass
-
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
